http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2575125-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_652893b83c1bb2eb6042ebc1cd9dcd28 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1883 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
| filingDate | 2010-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5667dadfbc3b94b755fe87227bdfed3b |
| publicationDate | 2016-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2575125-T3 |
| titleOfInvention | Neuregulin-based methods for the treatment of heart failure |
| abstract | Neuregulin 1 protein for use in a method for the prevention, treatment or retardation of heart failure in mammals that need it, wherein the method comprises administering it to the mammal in need of said neuregulin 1 protein in an amount: a ) from approximately 0.3 μg to approximately 2.4 μg / kg / day; b) from about 6 EU to about 48 EU / kg / day; or c) from about 0.04 nmol to about 0.34 nmol / kg / day. |
| priorityDate | 2009-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 145.